Relevance of hepatitis B core gene deletions in patients after kidney transplantation

Gastroenterology

Volumn 124, Issue 7, 2003, Pages 1809-1820

  Bock, C Thomas ^a   Buerke, Boris ^a   Tillmann, Hans L ^a   Tacke, Frank ^a   Kliem, Volker ^a   Manns, Michael P ^a   Trautwein, Christian ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GLUCOCORTICOID; HEPATITIS B CORE ANTIGEN; PREDNISOLONE;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXPRESSION VECTOR; GENE DELETION; GENE MUTATION; HEART TRANSPLANTATION; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MOLECULAR CLONING; NONHUMAN; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN LOCALIZATION; VIRUS CAPSID; VIRUS GENOME; VIRUS REPLICATION;

EID: 0038318912     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00396-2     Document Type: Article

References (38)

1. Kellerman S, Alter MJ. Preventing hepatitis B and hepatitis C virus infections in end-stage renal disease patients: back to basics. Hepatology 1999;29:291-293.
2. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virusrelated liver disease. Hepatology 1991;13:619-626.
3. Kliem V, Ringe B, Holhorst K, Frei U. Kidney transplantation in hepatitis B surface antigen carriers. Clin Invest 1994;72:1000-1006.
4. Wedemeyer H, Pethig K, Wagner D, Flemming P, Oppelt P, Petzold DR, Haverich A, Manns MP, Boeker KH. Long-term outcome of chronic hepatitis B in heart transplant recipients. Transplantation 1998;66:1347-1353.
5. Younossi ZM, Braun WE, Protiva DA, Gifford RW Jr, Straffon RA. Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years. Transplantation 1999;67: 272-275.
6. Yagisawa T, Toma H, Tanabe K, Ishikawa N, Tokumoto N, Iguchi Y, Goya N, Nakazawa H, Takahashi K, Ota K. Long-term outcome of renal transplantation in hepatitis B surface antigen-positive patients in cyclosporin era. Am J Nephrol 1997;17:440-444.
7. Mathurin P, Mouquet C, Poynard T, Sylla C, Benalia H, Fretz C, Thibault V, Cadranel JF, Bernard B, Opolon P, Coriat P, Bitker MO. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999;29:257-263.
8. Descamps-Latscha B, Chatenoud L. T cells and B cells in chronic renal failure. Semin Nephrol 1996;16:183-191.
9. Girndt M, Sester M, Sester U, Kaul H, Kohler H. Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int 2001;59: 1382-1389.
10. Köhler H, Meuer SC. Effects of interleukin-2 on hepatitis B vaccination in uraemic patients. Lancet 1994;344:1368-1369.
11. Degos F, Lugassy C, Degott C, Debure A, Carnot F, Theirs V, Tiollais P, Kreis H, Brechot C. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. A prospective study of 90 patients. Gastroenterology 1988;94:151-156.
12. Günther S, Piwon N, Iwanska A, Schilling R, Meisel H, Will H. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J Virol 1996;70:8318-8331.
13. Günther S, Baginski S, Kissel H, Reinke P, Kruger DH, Will H, Meisel H. Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end-stage liver disease. Hepatology 1996;24:751-758.
14. Marinos G, Torre F, Gunther S, Thomas MG, Will H, Williams R, Naoumov NV. Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection. Gastroenterology 1996;111:183-192.
15. Winkler M. Cyclosporin as baseline immunosuppression in solid organ transplantation. Biodrugs 2000;14:185-193.
16. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993;329:1842-1847.
17. Bock CT, Tillmann HL, Maschek HJ, Manns MP, Trautwein C. A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly. Gastroenterology 1997;113:1976-1982.
18. Trautwein C, Schrem H, Tillmann HL, Kubicka S, Walker D, Boker KH, Maschek HJ, Pichlmayr R, Manns MP. Hepatitis B virus mutations in the pre-S genome before and after liver transplantation. Hepatology 1996;24:482-488.
19. Bock CT, Malek NP, Tillmann HL, Manns MP, Trautwein C. The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro. J Virol 2000;74:2193-2202.
20. Birnbaum F, Nassal M. Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J Virol 1990; 64:3319-3330.
21. Koschel M, Thomssen R, Bruss V. Extensive mutagenesis of the hepatitis B virus core gene and mapping of mutations that allow capsid formation. J Virol 1999;73:2153-2160.
22. Koschel M, Oed D, Gerelsaikhan T, Thomssen R, Bruss V. Hepatitis B virus core gene mutations which block nucleocapsid envelopment. J Virol 2000;74:1-7.
23. Beames B, Lanford RE. Insertions within the hepatitis B virus capsid protein influence capsid formation and RNA encapsidation. J Virol 1995;69:6833-6838.
24. Borisova G, Arya B, Dislers A, Borschukova O, Tsibinogin V, Skrastina D, Eldarov MA, Pumpens P, Skryabin KG, Grens E. Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen. J Virol 1993; 67:3696-3701.
25. von Weizsäcker F, Köck J, Wieland S, Offensperger WB, Blum HE. Dominant negative mutants of the duck hepatitis B virus core protein interfere with RNA pregenome packaging and viral DNA synthesis. Hepatology 1999;30:308-315.
26. Böttcher B, Wynne SA, Crowther RA. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature 1997;386:88-91.
27. Conway JF, Cheng N, Zlotnick A, Wingfield PT, Stahl SJ, Steven AC. Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy. Nature 1997;386:91-94.
28. Zheng J, Schodel F, Peterson DL. The structure of hepadnaviral core antigens. Identification of free thiols and determination of the disulfide bonding pattern. J Biol Chem 1992;267:9422-9429.
29. Zlotnick A, Cheng N, Conway JF, Booy FP, Steven AC, Stahl SJ, Wingfield PT. Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein. Biochemistry 1996;35:7412-7421.
30. Yuan TT, Lin MH, Qiu SM, Shih C. Functional characterization of naturally occurring variants of human hepatitis B virus containing the core internal deletion mutation. J Virol 1998;72:2168-2176.
31. Nassal M, Rieger A, Steinau O. Topological analysis of the hepatitis B virus core particle by cysteine-cysteine cross-linking. J Mol Biol 1992;225:1013-1025.
32. Nassal M. The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 1992;66:4107-4116.
33. Gallina A, Bonelli F, Zentilin L, Rindi G, Muttini M, Milanesi G. A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids. J Virol 1989;63:4645-4652.
34. Kann M, Gerlich WH. Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus. J Virol 1994;68:7993-8000.
35. Schlicht HJ, Bartenschlager R, Schaller H. The duck hepatitis B virus core protein contains a highly phosphorylated C terminus that is essential for replication but not for RNA packaging. J Virol 1989;63:2995-3000.
36. Fouillot N, Tlouzeau S, Rossignol JM, Jean-Jean O. Translation of the hepatitis B virus P gene by ribosomal scanning as an alternative to internal initiation. J Virol 1993;67:4886-4895.
37. Rehermann B, Fowler P, Sidney J, Person J, Redeker A, Brown M, Moss B, Sette A, Chisari FV. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995;181:1047-1058.
38. Roingeard P, Romet-Lemonne JL, Leturcq D, Goudeau A, Essex M. Hepatitis B virus core antigen (HBc Ag) accumulation in an HBV nonproducer clone of HepG2-transfected cells is associated with cytopathic effect. Virology 1990;179:113-120.